Am J Transplant, Volume 21, Suppl 3 Archives - Page 76 of 139 - ATC Abstracts

2021 American Transplant Congress
Outcomes in Highly Sensitized Kidney Transplant Recipients Receiving DCD Organs
A. Diamond¹, L. Rodrigues², A. Di Carlo³, S. Karhadkar³
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Temple University, Philadelphia, PA, ³Surgery, Temple University Hospital, Philadelphia, PA
*Purpose: Highly sensitized (HS) patients experience longer wait times for kidney transplantation despite prioritization by the Kidney Allocation System. Kidney transplants performed from donors defined…
2021 American Transplant Congress
Efficacy of Hope: Analysis of Quality HIV+ Deceased Donor Organ Availability
G. E. Owens¹, B. Shelton¹, P. MacLennan¹, D. Sawinski², J. E. Locke¹
¹Transplant, University of Alabama at Birmingham, Birmingham, AL, ²Transplant, University of Pennsylvania, Philadeplphia, PA
*Purpose: The purpose of this study is to understand the number of organs actually available for HIV+ to HIV+ transplant utilizing data on a national…
2021 American Transplant Congress
The Impact of Health Literacy on Kidney Transplant Listing
G. Chen¹, J. Siahaan², L. Leon Novelo², I. Rizvi³, A. M. De Golovine⁴, A. R. Edwards⁴, A. Pai⁴, W. A. Dar³
¹Abdominal Transplant, Memorial Hermann Hospital, Houston, TX, ²Department of Biostatistics and Data Science, School of Public Health The University of Texas Health Science Center at Houston, Houston, TX, ³Department of Surgery, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX, ⁴Department of Internal Medicine, Renal Diseases and Hypertension, McGovern Medical School The University of Texas Health Science Center at Houston, Houston, TX
*Purpose: Limited health literacy has long been associated with poor health outcomes in the general population, but there have been few studies investigating the association…
2021 American Transplant Congress
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?
F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
¹University of Wisconsin, Madison, WI, ²University of Wisconsin, Verona, WI
*Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
2021 American Transplant Congress
Effect of Insulin versus Oral Agents on Early Glycemic Control Following Kidney Transplant
A. Petrosan, A. Santeusanio, R. Khaim, V. Delaney
Mount Sinai Hospital, New York, NY
*Purpose: Insulin therapy is commonly prescribed to treat hyperglycemia early post-kidney transplant (KTx) due to its widespread availability and ease of titration. Alternatively, there is…
2021 American Transplant Congress
A Question with Multiple Answers: Do Renal Transplant Recipients Require Steroid Maintenance Following Thymoglobulin Induction?
A. Aala, H. Patel, F. Cardarelli
Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: Anti-thymocyte globulin (ATG) has been used with good results in renal transplantation as induction therapy, followed by triple immunosuppression with calcineurin inhibitors, antimetabolites, and…
2021 American Transplant Congress
A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression
E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Outcomes with varying belatacept conversion protocols from calcineurin inhibitor (CNI)-based immunosuppression have been published but no standard protocol has been established. Beginning in 2012,…
2021 American Transplant Congress
Pill Burden in Belatacept versus Tacrolimus-Based Immunosuppression
S. Gattis, L. Lakhani, A. Basu
Emory Healthcare, Atlanta, GA
*Purpose: Medication non-adherence is a major barrier amongst renal transplant recipients, and improvement can be seen after reduction in pill burden. Belatacept versus tacrolimus-based immunosuppression…
2021 American Transplant Congress
The Evaluation of Living-Related Kidney Transplantation Donors in Autosomal-Dominant Polycystic Kidney Disease
T. Kikuchi¹, K. Unagami², Y. Kobari³, T. Yagisawa³, T. Kanzawa³, K. Omoto³, A. Uemura¹, H. Ishida², K. Tanabe³
¹Urology, Kindai University Hospital, Osaka, Japan, ²Organ transplant medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan, ³Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan
*Purpose: Autosomal-dominant polycystic kidney disease (ADPKD) is a progressive hereditary disease caused primarily by gene mutations, leading to multiple kidney cyst occurrence, kidney function deterioration,…
2021 American Transplant Congress
Urine Donor-derived Cell-free is Valuable for Predicting BK Polyomavirus-associated Nephropathy in Kidney Transplant Recipients
G. Huang¹, X. Chen¹, Y. Huang¹, J. Li¹, R. Deng¹, W. Chen², J. Qiu¹, S. Deng¹, G. Chen¹, Q. Fu¹, C. Wu¹, J. Fei¹, L. Liu¹, L. Chen¹, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Our previous study has proved that urine donor-derived cell-free DNA (dd-cfDNA) can assist in the diagnosis of BK polyomavirus-associated nephropathy (BKPyVAN), but its specificity…